Business
BioSpectrum Asia
Pfizer's Ghig Program Supports Efforts To Reduce Health Disparities In Asia
Globally, infectious diseases are responsible for an estimated 8.4 million deaths annually and are a leading cause of death worldwide, particularly among young children and marginalized populations in underserved communities. It is estimated that the rise of antimicrobial resistance (AMR) now accounts for approximately 700,000 of these deaths. Without action, this number could reach ten million deaths per year by 2050 and could cost the world an estimated $100 trillion in lost productivity in the same amount of time. The World Health Organization (WHO) included AMR in its list of ten threats to global health in 2019.
5 min |
October 2019
BioSpectrum Asia
Improved Regulatory Support Push Clinical Research In Asia
The prevalence of infectious and tropical diseases is creating an unmet clinical needs in emerging countries.
5 min |
October 2019
BioSpectrum Asia
“We Are Seeing An Increased Demand For Healthcare Solutions In Asia Pacific”
In an interaction with BioSpectrum Asia, Karen Reddington, President FedEx Express Asia Pacific, Singapore shared the approaches the company has taken to mitigate the risks of Asia’s Biopharma Supply Chain. Edited excerpts;
4 min |
October 2019
BioSpectrum Asia
Digital Transformation Of The Pharmaceutical Industry
The pharmaceutical industry has evolved from a traditional ‘do-it-all’ into a classical vertical model, with selective partnerships and outsourcing on the rise. With the tides of digital disruption and blurring lines between organizations, a federated model is set to evolve over the next decade.
2 min |